Endocrinology explores the complex network of hormones that regulate nearly every function in the human body, from metabolism and growth to mood and reproduction. When this delicate chemical signaling system falters, it can lead to a wide range of conditions, including diabetes, thyroid disorders, and fertility issues. Understanding these mechanisms is vital for developing treatments that restore balance and improve quality of life.

At Gist.Science, we make the latest research from medRxiv accessible to everyone. We process every new preprint in this category as it becomes available, transforming dense medical findings into clear, plain-language overviews alongside detailed technical summaries. This approach ensures that both curious readers and specialists can stay informed without getting lost in jargon.

Below are the latest endocrinology preprints we have processed, offering fresh insights into how our internal chemistry shapes health and disease.

🩺 endocrinology

Spatial transcriptomics maps distinct signatures of human intermuscular adipose expansion in mice

This study integrates human bulk transcriptomics with mouse spatial transcriptomics to define distinct stromal niches driving intermuscular adipose expansion in metabolic disease, revealing that EBF2-mediated lineage plasticity, rather than progenitor abundance, orchestrates this spatially organized remodeling.

Pathak, E., Tom, R. Z., Kim, M., Sachs, S., Zhang, Y., Walter, M., Pfluger, P. T., Feuchtinger, A., Dyar, K. A., Bergman (…)2026-06-26
🩺 endocrinology

Predicting county-level diagnosed diabetes prevalence in the United States using explainable gradient boosting and geographic interpretation

This study utilizes an explainable LightGBM framework integrated with diverse public data sources to accurately predict and geographically interpret county-level diagnosed diabetes prevalence across the United States, identifying poverty and food insecurity as dominant structural drivers while emphasizing that the resulting insights serve as model-based explanations rather than causal effects.

Yahaya, Y., Khan, S., Rani Saha, P., Meia, M. A. A.2026-06-26
🩺 endocrinology

Association of body composition, daily physical activity and handgrip strength with mortality, cardiovascular events and cancers in Japanese patients with diabetes

In a prospective cohort study of 2,024 Japanese patients with diabetes, higher visceral adipose tissue was found to increase cancer risk while greater handgrip strength offered protection against cardiovascular events, though neither body composition, daily physical activity, nor handgrip strength were independently associated with all-cause mortality.

Hamasaki, H., Taxiarchi, V. P.2026-06-11
🩺 endocrinology

Reduced fecal intestinal alkaline phosphatase is associated with gestational diabetes mellitus: A hospital-based multicentre cross-sectional study in Bangladesh

This hospital-based multicentre cross-sectional study in Bangladesh reveals that reduced fecal intestinal alkaline phosphatase levels are independently associated with gestational diabetes mellitus, suggesting a potential role for gut-derived metabolic dysregulation in the condition despite the marker's current limitation as a standalone diagnostic tool.

Chowdhury, P., Tofail, T., Akter, N., Islam, H., Bokshi, A., Sultana, M., Podder, S., Malo, M. S., Hasanat, M.2026-05-19
🩺 endocrinology

Using routine clinical features to classify adult-onset diabetes at diagnosis: the StartRight prospective observational study

The StartRight prospective observational study demonstrates that a classification model combining routine clinical features, such as lower age and BMI, unintentional weight loss, and high presentation glycaemia, with or without islet autoantibodies, achieves high accuracy in differentiating adult-onset type 1 from type 2 diabetes at diagnosis, outperforming current clinical guidance.

Knupp, J., Hill, A. V., Thomas, N. J., McDonald, T. J., Young, K. G., Fraser, D. P., Hattersley, A., McKinley, T., Shiel (…)2026-05-03
🩺 endocrinology

Legacy neuropsychiatric benefit after semaglutide is linked to maximum achieved dose and independent of the maximum weight lost

This large-scale observational study reveals that semaglutide treatment is associated with a sustained, dose-dependent reduction in the risk of various neuropsychiatric disorders that operates independently of weight loss, suggesting a direct beneficial effect via central nervous system GLP-1 receptor engagement.

murugadoss, k., Venkatakrishnan, A., Soundararajan, V.2026-04-23